Sbi Securities Co., Ltd. Taysha Gene Therapies, Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.9 Trillion
- Q3 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Taysha Gene Therapies, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 16 shares of TSHA stock, worth $67. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 80
80.0%
Holding current value
$67
Previous $185,000
71.89%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TSHA
# of Institutions
162Shares Held
247MCall Options Held
463KPut Options Held
246K-
Rtw Investments, LP New York, NY24.4MShares$103 Million1.03% of portfolio
-
Ra Capital Management, L.P. Boston, MA23.6MShares$99.2 Million1.27% of portfolio
-
Avoro Capital Advisors LLC New York, NY21.7MShares$91.4 Million0.93% of portfolio
-
Morgan Stanley New York, NY19.3MShares$81.3 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY13.4MShares$56.3 Million0.01% of portfolio
About Taysha Gene Therapies, Inc.
- Ticker TSHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,359,500
- Market Cap $204M
- Description
- Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...